Director, Analytical Development (Flow Cytometry & Method Validation)

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. Orca Bio is a late-stage biotechnology company redefining the transplant process by developing next-generation cell therapies with the goal of pr